查詢結果分析
相關文獻
- 淺談精神分裂症病人與代謝症候群
- Effect of Second Generation Antipsychotics on the Metabolic Syndrome Parameters in Patients with Schizophrenia
- Metabolic Effects of Paliperidone in a Patient with Schizophrenia
- 抗精神分裂症藥物相關之代謝症候群
- Dipyridamole併用抗精神病藥物治療精神分裂症之探討
- 抗精神病藥物、多巴胺與精神分裂症
- 服用Clozapine之精神分裂症病患罹患代謝症候群之盛行率
- 精神分裂症藥物--Paliperidone Palmitate之剖析
- 抗精神病藥物導致之代謝異常
- Research on Asian Prescription Patterns (REAP): Focusing on Data from Japan
頁籤選單縮合
題 名 | 淺談精神分裂症病人與代謝症候群=People with Schizophrenia and Metabolic Syndrome |
---|---|
作 者 | 陳建坊; 林界男; | 書刊名 | 藥學雜誌 |
卷 期 | 26:4=105 2010.12[民99.12] |
頁 次 | 頁139-144 |
分類號 | 418.21 |
關鍵詞 | 精神分裂症; 代謝症候群; 抗精神病藥物; Schizophrenia; Metabolic syndrome; Antipsychotic medications; |
語 文 | 中文(Chinese) |
中文摘要 | 患有嚴重精神病例如精神分裂症與雙極性躁鬱症的病人,較一般人有較高代謝症候群的盛行率。在這些心血管 -代謝風險因子中,部份因素也是因為精神病人不健康的生活型態所造成,包括不良的飲食及生活習慣。然而,近幾年來卻發現,抗精神病藥物存在著造成體重增加、血糖及血脂異常等代謝方面不良反應之風險。因此在抗精神病藥物的選擇上,除了療效外,也必須要考量病人心血管及代謝生理狀況與藥物可能帶來的不良反應之風險。在全人照護的精神下,藉由多方醫療專業的介入,將可兼顧抗精神病藥物的療效及安全,並促進病人邁向正常、健康之生活型態。 |
英文摘要 | People with severe mental illnesses (SMI), such as schizophrenia and bipolar disorder, have an increased prevalence rate of metabolic syndrome and more risk factors for cardiovascular disease and type 2 diabetes. Parts of the reasons are caused by their unhealthy lifestyle, including bad diet and sedentary behavior. But over recent years, it has become obvious that those antipsychotic medications have associated with well-defined adverse reactions in weight gain, changes in glucose and dyslipidemia. When choosing treatment medication, physicians should not only consider the efficacy but also patients' cardiovascular and metabolic syndrome risks and adverse reactions caused by medication. Multidisciplinary assessment of psychiatric and medical conditions is needed. Psychiatric treatment facilities should offer and promote healthy lifestyle interventions. |
本系統中英文摘要資訊取自各篇刊載內容。